Cytotoxicity of Selenium Immunoconjugates against Triple Negative Breast Cancer Cells

Within the subtypes of breast cancer, those identified as triple negative for expression of estrogen receptor α (ESR1), progesterone receptor (PR) and human epidermal growth factor 2 (HER2), account for 10⁻20% of breast cancers, yet result in 30% of global breast cancer-associated...

Full description

Bibliographic Details
Main Authors: Soni Khandelwal, Mallory Boylan, Julian E. Spallholz, Lauren Gollahon
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/19/11/3352